Market Price

612.08 

10.56 1.8%

as of May 06 '21

52 Week Range:

567.00 745.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Germany, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, mixes critical drugs, controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 57.85
66.38
66.71
74.92
81.73
76.32
87.18
97.20
110.72
125.23
130.40
growth rate 14.8% 0.5% 12.3% 9.1% -6.6% 14.2% 11.5% 13.9% 13.1% 4.1%
Earnings BIT 31.99
39.48
35.08
39.27
40.82
42.51
39.13
41.27
41.71
40.53
35.67
growth rate 23.4% -11.1% 11.9% 3.9% 4.2% -8.0% 5.5% 1.1% -2.8% -12.0%
Avg.PE 17.39
18.73
16.81
22.47
24.00
25.18
31.62
29.88
42.70
37.22
35.21
growth rate 7.7% -10.3% 33.7% 6.8% 4.9% 25.6% -5.5% 42.9% -12.8% -5.4%
ROA 15.67
17.56
14.87
16.21
16.19
17.23
15.90
18.94
15.75
14.91
12.14
growth rate 12.1% -15.3% 9.0% -0.1% 6.4% -7.7% 19.1% -16.8% -5.3% -18.6%
ROE 17.96
20.41
17.29
18.73
18.63
19.70
17.96
21.07
17.34
16.39
13.43
growth rate 13.6% -15.3% 8.3% -0.5% 5.7% -8.8% 17.3% -17.7% -5.5% -18.1%
ROIC 17.39
19.74
16.58
18.11
18.10
19.33
17.76
21.07
16.65
15.44
12.92
growth rate 13.5% -16.0% 9.2% -0.1% 6.8% -8.1% 18.6% -21.0% -7.3% -16.3%
Cur. Ratio 6.71
8.34
7.87
9.65
7.46
8.40
10.37
11.98
11.96
11.74
8.24
growth rate 24.3% -5.6% 22.6% -22.7% 12.6% 23.5% 15.5% -0.2% -1.8% -29.8%
Quick Ratio 4.24
5.59
4.06
6.52
4.11
4.83
6.75
8.59
8.36
7.77
4.26
growth rate 31.8% -27.4% 60.6% -37.0% 17.5% 39.8% 27.3% -2.7% -7.1% -45.2%
Leverage 1.15
1.17
1.16
1.15
1.15
1.14
1.12
1.11
1.09
1.10
1.11
growth rate 1.7% -0.9% -0.9% 0.0% -0.9% -1.8% -0.9% -1.8% 0.9% 0.9%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 11.50
11.98
13.68
15.54
16.96
17.82
18.09
17.08
18.19
18.89
17.97
growth rate 4.2% 14.2% 13.6% 9.2% 5.1% 1.5% -5.6% 6.6% 3.8% -4.9%
Acct.Payable 10.04
7.21
9.36
4.53
3.93
4.03
3.93
5.08
5.71
6.64
growth rate -28.2% 29.9% -51.6% -13.3% 2.6% -2.5% 29.4% 12.3% 16.3%
Cur.Assets 52.00
83.74
56.75
90.32
74.14
78.30
93.46
115.23
122.27
132.34
112.32
growth rate 61.0% -32.2% 59.2% -17.9% 5.6% 19.4% 23.3% 6.1% 8.2% -15.1%
Total Assets 134.70
161.90
155.81
172.07
171.51
164.34
181.94
203.78
231.22
262.03
266.89
growth rate 20.2% -3.8% 10.4% -0.3% -4.2% 10.7% 12.0% 13.5% 13.3% 1.9%
Cash 10.70
24.59
8.00
28.56
20.78
28.35
20.02
30.14
58.75
45.05
22.45
growth rate 129.8% -67.5% 257.0% -27.3% 36.4% -29.4% 50.5% 95.0% -23.3% -50.2%
Inventory 17.40
24.58
23.78
26.27
28.02
29.77
29.02
29.35
33.57
42.09
50.30
growth rate 41.3% -3.3% 10.5% 6.7% 6.2% -2.5% 1.2% 14.4% 25.4% 19.5%
Cur.Liabilities 7.80
10.04
7.21
9.36
9.94
9.32
9.07
9.62
10.22
11.27
13.64
growth rate 28.8% -28.2% 29.9% 6.1% -6.2% -2.6% 6.1% 6.2% 10.3% 21.0%
Liabilities 18.00
23.38
20.98
23.07
21.94
20.24
18.95
19.39
20.45
24.16
26.45
growth rate 29.9% -10.3% 10.0% -4.9% -7.8% -6.3% 2.3% 5.5% 18.2% 9.5%
LT Debt 0.00 0.00 0.00
growth rate
Equity 116.60
138.51
134.83
148.99
149.57
144.10
162.99
184.39
210.77
237.87
240.44
growth rate 18.8% -2.7% 10.5% 0.4% -3.7% 13.1% 13.1% 14.3% 12.9% 1.1%
Common Shares 2.00
2.00
2.00
2.00
2.00
2.00
2.00
2.00
2.00
2.00
2.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 4.30
12.00
10.35
7.50
12.67
9.32
10.64
9.68
17.51
20.45
21.89
growth rate 179.1% -13.8% -27.5% 68.9% -26.4% 14.1% -9.0% 80.9% 16.8% 7.0%
Cash Dividends 21.30
3.68
24.46
4.82
5.43
6.07
7.11
8.32
9.45
10.76
12.10
growth rate -82.7% 565.4% -80.3% 12.7% 11.7% 17.2% 17.0% 13.6% 13.8% 12.5%
Cash From OA 31.10
31.54
29.37
36.58
31.22
40.43
37.40
47.04
43.24
42.47
38.97
growth rate 1.4% -6.9% 24.5% -14.6% 29.5% -7.5% 25.8% -8.1% -1.8% -8.2%
FCF per Share 13.27
11.24
9.38
13.04
9.48
14.91
14.19
19.77
15.00
14.30
8.08
growth rate -15.3% -16.6% 39.0% -27.3% 57.3% -4.8% 39.3% -24.1% -4.7% -43.5%
Sale Purchase of Stock -1.51
-4.61
-9.20
-23.56
-30.70
-1.28
-0.09
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF 27.00
19.00
19.00
27.00
19.00
31.00
27.00
37.00
26.00
22.00
17.00
growth rate -29.6% 0.0% 42.1% -29.6% 63.2% -12.9% 37.0% -29.7% -15.4% -22.7%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 108.60
117.70
119.06
131.99
140.76
145.73
143.49
146.60
152.45
155.07
147.59
growth rate 8.4% 1.2% 10.9% 6.6% 3.5% -1.5% 2.2% 4.0% 1.7% -4.8%
Op.Income 31.00
26.04
23.63
26.58
40.82
42.51
39.13
41.27
41.71
40.53
35.67
growth rate -16.0% -9.3% 12.5% 53.6% 4.2% -8.0% 5.5% 1.1% -2.8% -12.0%
IBT 32.00
39.48
35.08
39.27
42.02
40.87
39.27
42.34
42.04
43.17
38.47
growth rate 23.4% -11.2% 12.0% 7.0% -2.7% -3.9% 7.8% -0.7% 2.7% -10.9%
Net Income 21.00
26.04
23.63
26.58
27.81
28.93
27.58
36.59
34.26
36.76
32.12
growth rate 24.0% -9.3% 12.5% 4.6% 4.0% -4.7% 32.7% -6.4% 7.3% -12.6%
EPS 10.32
12.82
11.66
13.18
14.08
15.47
14.85
19.71
18.44
19.73
17.44
growth rate 24.2% -9.1% 13.0% 6.8% 9.9% -4.0% 32.7% -6.4% 7.0% -11.6%
Gross Profit 50.90
60.01
56.14
63.06
68.52
70.98
67.63
70.75
71.78
70.69
66.16
growth rate 17.9% -6.4% 12.3% 8.7% 3.6% -4.7% 4.6% 1.5% -1.5% -6.4%
R&D 2.70
2.87
3.77
4.29
5.29
6.35
6.57
5.80
5.51
5.04
5.65
growth rate 6.2% 31.3% 13.9% 23.3% 20.1% 3.6% -11.8% -4.9% -8.6% 12.1%

Quarterly Statements

Item Name Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Earnings BIT 8.08
11.71
10.05
7.58
6.33
growth rate 45.1% -14.2% -24.5% -16.6%
Balance Sheet Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Acct.Receivable 18.89
22.81
22.44
17.75
17.97
growth rate 20.8% -1.6% -20.9% 1.3%
Acct.Payable 5.71
10.33
11.37
11.69
6.64
growth rate 80.9% 10.2% 2.8% -43.3%
Cur.Assets 132.34
128.08
102.15
113.16
112.32
growth rate -3.2% -20.3% 10.8% -0.7%
Total Assets 262.03
260.43
260.35
263.03
266.89
growth rate -0.6% 0.0% 1.0% 1.5%
Cash 45.05
44.08
24.10
24.00
22.45
growth rate -2.2% -45.3% -0.4% -6.4%
Inventory 42.09
41.25
45.81
48.62
50.30
growth rate -2.0% 11.0% 6.2% 3.5%
Cur.Liabilities 11.27
12.96
15.44
12.70
13.64
growth rate 15.0% 19.2% -17.8% 7.4%
Liabilities 24.16
25.43
26.82
24.91
26.45
growth rate 5.3% 5.5% -7.1% 6.2%
LT Debt
growth rate
Equity 237.87
235.00
233.53
238.12
240.44
growth rate -1.2% -0.6% 2.0% 1.0%
Common Shares 1.86
0.34
0.34
0.34
0.34
growth rate -81.6% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Capital Expenditures 35.69
3.57
5.23
6.10
6.99
growth rate -90.0% 46.2% 16.7% 14.6%
Cash Dividends -18.64
2.87
2.84
3.20
3.19
growth rate 100.0% -1.1% 12.8% -0.3%
Cash From OA 6.30
12.83
6.59
9.33
10.22
growth rate 103.7% -48.6% 41.5% 9.6%
Sale Purchase of Stock -9.25
-7.79
34.07
growth rate 0.0% 100.0%
FCF -29.39
9.26
1.37
3.23
3.23
growth rate 100.0% -85.2% 136.2% 0.2%
Income Statement Dec '19 Mar '20 Jun '20 Sep '20 Dec '20
Sales 34.47
43.59
37.97
33.79
32.24
growth rate 26.5% -12.9% -11.0% -4.6%
Op.Income 8.08
11.71
10.05
7.58
6.33
growth rate 45.1% -14.2% -24.5% -16.6%
IBT 12.55
11.18
10.77
8.56
7.96
growth rate -10.9% -3.7% -20.5% -7.1%
Net Income 8.06
8.90
8.61
7.24
7.37
growth rate 10.3% -3.3% -15.8% 1.8%
EPS
growth rate
Gross Profit 15.50
19.87
17.47
14.90
13.93
growth rate 28.2% -12.1% -14.7% -6.5%
R&D 1.36
1.68
1.09
1.39
1.48
growth rate 23.8% -35.2% 27.1% 6.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (16.86)

YOY Growth Grade:

E (28.40)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 36.62 35.10 20.70
EPS / Growth 10.9% 17.44 15.8%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 7.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 7.5% 11.4% 11.4%
Future PE 14.96 26.70 26.70
Future EPS 35.88 51.29 51.29
Value Price
MOS %
132.67
-78.3%
338.49
-44.7%
338.49
-44.7%
MOS Price 66.34 169.24 169.24
IRT 17.13 14.12 14.12

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.